Shilpa Medicare has launched first time in the world Oral Thin Film formulation, a pediatric dose Paracetamol Oral Thin Film, under the Brand name Molshil. Shilpa received approval for Molshil Oral Thin Films after sufficiently complying bioequivalence requirements. Shilpa's Paracetamol Oral Thin Films are patent protected and are first of this kind in the world.Shilpa has manufacturing facilities for paracetamol at both Hyderabad and Bangalore. The company has launched Paracetamol Oral Thin Films as 60 mg and 120 mg strengths in Orange Flavor.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: